Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China · Delayed Price · Currency is CNY 20.08
-0.36 (-1.76%)
Nov 6, 2026, 11:05 AM CST
SHE:002880 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 87.76 | 369.81 | 274.76 | 252.3 | 294.59 | 332.1 |
Short-Term Investments | - | - | 153.32 | 21.47 | - | - |
Cash & Short-Term Investments | 87.76 | 369.81 | 428.08 | 273.77 | 294.59 | 332.1 |
Cash Growth | 10.25% | -13.61% | 56.36% | -7.07% | -11.30% | -29.58% |
Accounts Receivable | 365.19 | 410.57 | 284.26 | 133.91 | 208.46 | 204.25 |
Other Receivables | 23.34 | 17.47 | 16.8 | 5.05 | 4.65 | 1.62 |
Receivables | 388.53 | 428.04 | 301.06 | 138.96 | 213.11 | 205.87 |
Inventory | 1,107 | 882.73 | 793.46 | 672.98 | 605.51 | 421.68 |
Other Current Assets | 11.24 | 5.84 | 4.99 | 17.98 | 19.92 | 39.71 |
Total Current Assets | 1,595 | 1,686 | 1,528 | 1,104 | 1,133 | 999.36 |
Property, Plant & Equipment | 616.2 | 619.42 | 691.09 | 683.19 | 1,045 | 785.22 |
Long-Term Investments | 111.96 | 322.88 | 77.67 | 86.72 | 83.49 | 69.17 |
Goodwill | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 |
Other Intangible Assets | 146.35 | 150.77 | 134.91 | 136.8 | 75.11 | 76.26 |
Long-Term Deferred Tax Assets | 18.12 | 22.72 | 9.97 | 10.54 | 2.73 | 3.07 |
Long-Term Deferred Charges | 61.58 | 52.66 | 28.34 | 24.75 | 22.77 | 19.41 |
Other Long-Term Assets | 1,039 | 865.95 | 808.65 | 811.85 | 194.62 | 31.79 |
Total Assets | 3,607 | 3,740 | 3,297 | 2,877 | 2,576 | 2,004 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 81.67 | 112.82 | 137.14 | 77.55 | 33.14 | 28.97 |
Accrued Expenses | 74.9 | 200.97 | 135.98 | 124.66 | 75.57 | 87.25 |
Short-Term Debt | 294.28 | 294.63 | 111.49 | 11.06 | 100.09 | 25 |
Current Portion of Long-Term Debt | 47.35 | 46.34 | 14.74 | 24.15 | - | - |
Current Portion of Leases | - | 1.39 | 1.64 | 1.46 | 1.32 | 1.39 |
Current Income Taxes Payable | 11.35 | 21.7 | 9.68 | 11.34 | 5.08 | 14.88 |
Current Unearned Revenue | 1.1 | 21.84 | 0.76 | 3.2 | 7.8 | 2.4 |
Other Current Liabilities | 71.9 | 12.24 | 11.33 | 12.57 | 6.76 | 7.26 |
Total Current Liabilities | 582.54 | 711.94 | 422.75 | 265.99 | 229.76 | 167.15 |
Long-Term Debt | 457.66 | 493.22 | 554.1 | 483.71 | 428.96 | - |
Long-Term Leases | 15.44 | 14.71 | 15.32 | 16.08 | 16.66 | 17.04 |
Long-Term Unearned Revenue | 53.9 | 58.5 | 43.27 | 46.78 | 25.92 | 23.98 |
Long-Term Deferred Tax Liabilities | 10.76 | 10.97 | 11.72 | 12.54 | 0.86 | 1.01 |
Other Long-Term Liabilities | 5.58 | 5.58 | 6.05 | 6.05 | 6.05 | 6.05 |
Total Liabilities | 1,126 | 1,295 | 1,053 | 831.14 | 708.2 | 215.23 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 226.8 | 226.8 | 226.8 | 226.8 | 226.8 | 226.8 |
Additional Paid-In Capital | 563.49 | 563.49 | 563.49 | 574.5 | 574.5 | 574.5 |
Retained Earnings | 1,658 | 1,622 | 1,421 | 1,213 | 1,040 | 967.42 |
Total Common Equity | 2,448 | 2,412 | 2,211 | 2,014 | 1,841 | 1,769 |
Minority Interest | 32.86 | 32.76 | 32.81 | 31.36 | 26.77 | 19.55 |
Shareholders' Equity | 2,481 | 2,445 | 2,244 | 2,046 | 1,868 | 1,788 |
Total Liabilities & Equity | 3,607 | 3,740 | 3,297 | 2,877 | 2,576 | 2,004 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 814.73 | 850.29 | 697.28 | 536.46 | 547.02 | 43.42 |
Net Cash (Debt) | -726.96 | -480.47 | -269.21 | -262.69 | -252.44 | 288.68 |
Net Cash Growth | - | - | - | - | - | -25.90% |
Net Cash Per Share | -3.21 | -2.12 | -1.19 | -1.16 | -1.11 | 1.27 |
Filing Date Shares Outstanding | 226.88 | 226.8 | 226.8 | 226.8 | 226.8 | 226.8 |
Total Common Shares Outstanding | 226.88 | 226.8 | 226.8 | 226.8 | 226.8 | 226.8 |
Working Capital | 1,012 | 974.49 | 1,105 | 837.72 | 903.37 | 832.2 |
Book Value Per Share | 10.79 | 10.64 | 9.75 | 8.88 | 8.12 | 7.80 |
Tangible Book Value | 2,283 | 2,242 | 2,057 | 1,858 | 1,747 | 1,673 |
Tangible Book Value Per Share | 10.06 | 9.89 | 9.07 | 8.19 | 7.70 | 7.38 |
Buildings | - | 278.72 | 367.81 | 341.65 | 318.11 | 269.13 |
Machinery | - | 915.14 | 798.15 | 701.71 | 590.44 | 516.79 |
Construction In Progress | - | 20.87 | 42.23 | 91.69 | 536.42 | 342.36 |